 Mohamed Awad
Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Limbs | 10 | 2025 | 200 | 2.620 |
Why?
| | Arthroplasty, Replacement, Hip | 6 | 2024 | 177 | 2.170 |
Why?
| | Osseointegration | 5 | 2025 | 71 | 1.260 |
Why?
| | Surgical Wound Infection | 5 | 2025 | 307 | 1.250 |
Why?
| | Fractures, Open | 2 | 2025 | 29 | 1.050 |
Why?
| | Lower Extremity | 3 | 2025 | 427 | 1.030 |
Why?
| | Pain, Postoperative | 2 | 2019 | 265 | 1.010 |
Why?
| | Antibiotic Prophylaxis | 1 | 2024 | 119 | 0.820 |
Why?
| | Arthroplasty, Replacement, Knee | 4 | 2024 | 363 | 0.820 |
Why?
| | Spine | 1 | 2024 | 173 | 0.790 |
Why?
| | Bisphosphonate-Associated Osteonecrosis of the Jaw | 2 | 2019 | 5 | 0.780 |
Why?
| | Osteonecrosis | 2 | 2020 | 24 | 0.780 |
Why?
| | Orthopedic Procedures | 3 | 2024 | 216 | 0.750 |
Why?
| | Bone Density Conservation Agents | 2 | 2020 | 80 | 0.750 |
Why?
| | Arthroplasty, Replacement | 2 | 2019 | 45 | 0.740 |
Why?
| | Anti-Bacterial Agents | 4 | 2025 | 1809 | 0.650 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 52 | 0.650 |
Why?
| | Communicable Disease Control | 1 | 2020 | 82 | 0.640 |
Why?
| | Pharmacogenomic Variants | 1 | 2019 | 35 | 0.610 |
Why?
| | Mandibular Reconstruction | 1 | 2019 | 12 | 0.610 |
Why?
| | Cytochrome P450 Family 3 | 1 | 2018 | 3 | 0.600 |
Why?
| | Drug Interactions | 2 | 2022 | 410 | 0.600 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 64 | 0.590 |
Why?
| | Fibula | 1 | 2019 | 43 | 0.590 |
Why?
| | Operating Rooms | 1 | 2020 | 123 | 0.590 |
Why?
| | Free Tissue Flaps | 1 | 2019 | 52 | 0.570 |
Why?
| | DNA, Plant | 1 | 2017 | 15 | 0.560 |
Why?
| | Triticum | 1 | 2017 | 17 | 0.560 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2017 | 22 | 0.560 |
Why?
| | Genome, Chloroplast | 1 | 2017 | 7 | 0.560 |
Why?
| | Pharmacogenetics | 1 | 2018 | 180 | 0.530 |
Why?
| | Analgesics, Opioid | 3 | 2022 | 1000 | 0.530 |
Why?
| | Femur | 5 | 2025 | 254 | 0.520 |
Why?
| | Orthopedics | 3 | 2024 | 144 | 0.510 |
Why?
| | Quality of Life | 2 | 2025 | 2892 | 0.470 |
Why?
| | Pandemics | 2 | 2022 | 1639 | 0.460 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.460 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.460 |
Why?
| | Walking | 5 | 2024 | 529 | 0.420 |
Why?
| | Vancomycin | 2 | 2025 | 84 | 0.420 |
Why?
| | Humans | 42 | 2025 | 137585 | 0.360 |
Why?
| | Cardiology | 3 | 2018 | 274 | 0.350 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 402 | 0.340 |
Why?
| | Osteoclasts | 3 | 2020 | 52 | 0.330 |
Why?
| | Bone Marrow | 2 | 2023 | 286 | 0.320 |
Why?
| | Amputees | 3 | 2025 | 96 | 0.310 |
Why?
| | Length of Stay | 3 | 2024 | 1215 | 0.300 |
Why?
| | Diphosphonates | 2 | 2019 | 66 | 0.290 |
Why?
| | Hip Joint | 3 | 2024 | 171 | 0.280 |
Why?
| | Gait | 3 | 2024 | 296 | 0.260 |
Why?
| | Laparoscopy | 2 | 2022 | 466 | 0.260 |
Why?
| | Prosthesis Design | 2 | 2025 | 327 | 0.250 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3284 | 0.250 |
Why?
| | Tobramycin | 1 | 2025 | 52 | 0.230 |
Why?
| | Spectrin | 1 | 2024 | 14 | 0.230 |
Why?
| | Bone Cements | 1 | 2024 | 43 | 0.220 |
Why?
| | Hypertension | 3 | 2018 | 1295 | 0.220 |
Why?
| | Surgical Drapes | 1 | 2024 | 2 | 0.220 |
Why?
| | Joints | 1 | 2025 | 105 | 0.220 |
Why?
| | Biomechanical Phenomena | 5 | 2025 | 810 | 0.210 |
Why?
| | Osteogenesis | 2 | 2023 | 188 | 0.210 |
Why?
| | Microfilament Proteins | 1 | 2024 | 133 | 0.210 |
Why?
| | Orthopedic Surgeons | 1 | 2024 | 27 | 0.210 |
Why?
| | Functional Laterality | 1 | 2024 | 223 | 0.210 |
Why?
| | Mechanotransduction, Cellular | 1 | 2024 | 111 | 0.210 |
Why?
| | Extracellular Traps | 1 | 2023 | 53 | 0.200 |
Why?
| | Fracture Fixation | 1 | 2023 | 75 | 0.200 |
Why?
| | Tibia | 1 | 2024 | 178 | 0.200 |
Why?
| | Testicular Hydrocele | 1 | 2022 | 4 | 0.190 |
Why?
| | Stroke | 2 | 2021 | 1120 | 0.190 |
Why?
| | Collateral Ligaments | 1 | 2021 | 16 | 0.190 |
Why?
| | Receptors, Angiotensin | 1 | 2021 | 12 | 0.180 |
Why?
| | Pressure Ulcer | 1 | 2022 | 46 | 0.180 |
Why?
| | Tooth Extraction | 2 | 2020 | 25 | 0.180 |
Why?
| | Hernia, Inguinal | 1 | 2022 | 36 | 0.180 |
Why?
| | Meniscus | 1 | 2021 | 22 | 0.180 |
Why?
| | Adult | 10 | 2025 | 37929 | 0.180 |
Why?
| | Probability | 1 | 2022 | 304 | 0.180 |
Why?
| | Trigger Finger Disorder | 1 | 2020 | 6 | 0.180 |
Why?
| | Social Media | 1 | 2024 | 158 | 0.170 |
Why?
| | Operative Time | 1 | 2021 | 145 | 0.170 |
Why?
| | Tissue Preservation | 1 | 2020 | 12 | 0.170 |
Why?
| | Knee Injuries | 1 | 2021 | 99 | 0.170 |
Why?
| | Blood Loss, Surgical | 1 | 2021 | 101 | 0.170 |
Why?
| | Male | 16 | 2025 | 67762 | 0.170 |
Why?
| | Respiratory Protective Devices | 1 | 2020 | 14 | 0.170 |
Why?
| | Jaw Diseases | 1 | 2020 | 4 | 0.170 |
Why?
| | Carrier Proteins | 1 | 2024 | 771 | 0.160 |
Why?
| | Cell Differentiation | 4 | 2023 | 1991 | 0.160 |
Why?
| | Bone and Bones | 2 | 2020 | 317 | 0.160 |
Why?
| | Urinary Tract Infections | 1 | 2022 | 188 | 0.160 |
Why?
| | Osteoarthritis, Knee | 1 | 2023 | 254 | 0.160 |
Why?
| | Surgeons | 1 | 2024 | 297 | 0.160 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2021 | 159 | 0.160 |
Why?
| | Polymorphism, Genetic | 1 | 2022 | 660 | 0.160 |
Why?
| | Teratoma | 1 | 2020 | 114 | 0.150 |
Why?
| | Consensus | 2 | 2025 | 683 | 0.150 |
Why?
| | Peptide Hormones | 1 | 2019 | 11 | 0.150 |
Why?
| | Dipeptidyl Peptidase 4 | 1 | 2019 | 13 | 0.150 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2019 | 204 | 0.150 |
Why?
| | Cerebrovascular Circulation | 2 | 2019 | 243 | 0.150 |
Why?
| | Time Factors | 3 | 2025 | 6828 | 0.150 |
Why?
| | Collagen Type I | 1 | 2019 | 136 | 0.150 |
Why?
| | Ovary | 1 | 2020 | 221 | 0.150 |
Why?
| | Perioperative Care | 1 | 2020 | 178 | 0.150 |
Why?
| | Bone Resorption | 1 | 2019 | 86 | 0.150 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 117 | 0.140 |
Why?
| | Bone Transplantation | 1 | 2019 | 90 | 0.140 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 316 | 0.140 |
Why?
| | Jaw | 1 | 2018 | 26 | 0.140 |
Why?
| | Malnutrition | 1 | 2019 | 83 | 0.140 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2018 | 33 | 0.140 |
Why?
| | Inservice Training | 1 | 2018 | 116 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1477 | 0.140 |
Why?
| | Dementia, Vascular | 1 | 2017 | 20 | 0.140 |
Why?
| | Certification | 1 | 2018 | 113 | 0.140 |
Why?
| | Occupational Health | 1 | 2020 | 200 | 0.140 |
Why?
| | Education, Medical, Continuing | 1 | 2018 | 127 | 0.140 |
Why?
| | Female | 12 | 2025 | 73304 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.130 |
Why?
| | Physical Conditioning, Animal | 1 | 2019 | 257 | 0.130 |
Why?
| | Recovery of Function | 1 | 2021 | 653 | 0.130 |
Why?
| | Ischemic Preconditioning | 1 | 2017 | 41 | 0.130 |
Why?
| | Aged | 6 | 2025 | 23961 | 0.130 |
Why?
| | Patient Safety | 1 | 2020 | 314 | 0.130 |
Why?
| | Preoperative Care | 1 | 2019 | 362 | 0.130 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 146 | 0.130 |
Why?
| | Dendritic Cells | 1 | 2020 | 483 | 0.130 |
Why?
| | Patient Readmission | 1 | 2022 | 697 | 0.130 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 382 | 0.130 |
Why?
| | Nutritional Status | 1 | 2019 | 350 | 0.130 |
Why?
| | Cytokines | 3 | 2019 | 2085 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1587 | 0.130 |
Why?
| | Middle Aged | 7 | 2025 | 33479 | 0.120 |
Why?
| | Homeostasis | 1 | 2020 | 621 | 0.120 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 660 | 0.120 |
Why?
| | Program Evaluation | 1 | 2020 | 898 | 0.120 |
Why?
| | Primary Prevention | 1 | 2017 | 196 | 0.120 |
Why?
| | Postoperative Complications | 3 | 2022 | 2654 | 0.120 |
Why?
| | Vascular Remodeling | 1 | 2017 | 193 | 0.120 |
Why?
| | Pain Management | 1 | 2018 | 352 | 0.120 |
Why?
| | Antihypertensive Agents | 1 | 2018 | 494 | 0.110 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 565 | 0.110 |
Why?
| | Emergency Medical Services | 1 | 2020 | 552 | 0.110 |
Why?
| | Pediatrics | 1 | 2022 | 1101 | 0.100 |
Why?
| | Brain Injuries, Traumatic | 1 | 2019 | 360 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1724 | 0.100 |
Why?
| | Arthroplasty | 2 | 2024 | 52 | 0.100 |
Why?
| | Peptides | 1 | 2019 | 985 | 0.100 |
Why?
| | Societies, Medical | 1 | 2017 | 820 | 0.100 |
Why?
| | Retrospective Studies | 4 | 2025 | 15657 | 0.100 |
Why?
| | Disease Management | 1 | 2017 | 628 | 0.100 |
Why?
| | Computational Biology | 1 | 2017 | 644 | 0.100 |
Why?
| | Animals | 11 | 2024 | 36940 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 383 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 1040 | 0.090 |
Why?
| | Prosthesis Implantation | 2 | 2023 | 153 | 0.090 |
Why?
| | Mice | 7 | 2024 | 17787 | 0.090 |
Why?
| | Blood Pressure | 1 | 2018 | 1786 | 0.090 |
Why?
| | Biomarkers | 2 | 2019 | 4149 | 0.090 |
Why?
| | Knee Joint | 2 | 2025 | 409 | 0.080 |
Why?
| | Body Mass Index | 1 | 2019 | 2389 | 0.080 |
Why?
| | Imidazoles | 2 | 2021 | 238 | 0.080 |
Why?
| | X-Ray Microtomography | 2 | 2019 | 94 | 0.070 |
Why?
| | Brain | 1 | 2019 | 2668 | 0.070 |
Why?
| | Africa South of the Sahara | 2 | 2017 | 48 | 0.070 |
Why?
| | Wound Healing | 2 | 2020 | 331 | 0.060 |
Why?
| | United States | 2 | 2022 | 14841 | 0.060 |
Why?
| | Rats | 3 | 2021 | 5647 | 0.060 |
Why?
| | Inflammation | 3 | 2023 | 2837 | 0.060 |
Why?
| | Powders | 1 | 2025 | 43 | 0.060 |
Why?
| | Administration, Topical | 1 | 2025 | 151 | 0.060 |
Why?
| | Osteocytes | 1 | 2024 | 28 | 0.060 |
Why?
| | Iodophors | 1 | 2024 | 3 | 0.050 |
Why?
| | Canada | 1 | 2025 | 418 | 0.050 |
Why?
| | Prosthesis-Related Infections | 1 | 2024 | 95 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 280 | 0.050 |
Why?
| | Foot | 1 | 2024 | 96 | 0.050 |
Why?
| | Postoperative Period | 1 | 2024 | 342 | 0.050 |
Why?
| | Weight-Bearing | 1 | 2024 | 173 | 0.050 |
Why?
| | Movement | 1 | 2025 | 278 | 0.050 |
Why?
| | Scandinavian and Nordic Countries | 1 | 2022 | 13 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 55 | 0.050 |
Why?
| | Glycosylation | 1 | 2023 | 151 | 0.050 |
Why?
| | Pain Measurement | 1 | 2025 | 521 | 0.050 |
Why?
| | Stress, Mechanical | 1 | 2024 | 485 | 0.050 |
Why?
| | Inguinal Canal | 1 | 2022 | 10 | 0.050 |
Why?
| | Anti-Infective Agents | 1 | 2024 | 255 | 0.050 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2022 | 155 | 0.050 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2021 | 9 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2023 | 316 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2022 | 77 | 0.050 |
Why?
| | Range of Motion, Articular | 1 | 2024 | 393 | 0.050 |
Why?
| | Iatrogenic Disease | 1 | 2022 | 67 | 0.050 |
Why?
| | Postural Balance | 1 | 2024 | 215 | 0.050 |
Why?
| | Menisci, Tibial | 1 | 2021 | 61 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 283 | 0.040 |
Why?
| | Cell Survival | 1 | 2024 | 1120 | 0.040 |
Why?
| | Cell Membrane | 1 | 2024 | 738 | 0.040 |
Why?
| | Thiophenes | 1 | 2021 | 117 | 0.040 |
Why?
| | Arthroscopy | 1 | 2021 | 222 | 0.040 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 167 | 0.040 |
Why?
| | Health Policy | 1 | 2022 | 388 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2019 | 92 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2607 | 0.040 |
Why?
| | Equipment Design | 1 | 2020 | 522 | 0.040 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2018 | 5 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2019 | 455 | 0.040 |
Why?
| | Africa | 1 | 2018 | 108 | 0.040 |
Why?
| | Proteolysis | 1 | 2019 | 177 | 0.040 |
Why?
| | Edetic Acid | 1 | 2018 | 50 | 0.040 |
Why?
| | Molar | 1 | 2018 | 49 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2018 | 93 | 0.040 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2018 | 87 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 50 | 0.040 |
Why?
| | Intervertebral Disc | 1 | 2018 | 39 | 0.040 |
Why?
| | Ultrasonography | 1 | 2021 | 759 | 0.030 |
Why?
| | Chelating Agents | 1 | 2018 | 75 | 0.030 |
Why?
| | Myelin Basic Protein | 1 | 2017 | 47 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 10811 | 0.030 |
Why?
| | Sulfonamides | 1 | 2021 | 513 | 0.030 |
Why?
| | Neutrophils | 1 | 2023 | 1238 | 0.030 |
Why?
| | Maze Learning | 1 | 2017 | 103 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2024 | 3015 | 0.030 |
Why?
| | Nitrites | 1 | 2017 | 84 | 0.030 |
Why?
| | Pain | 1 | 2023 | 756 | 0.030 |
Why?
| | Infant | 2 | 2022 | 9465 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 172 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1946 | 0.030 |
Why?
| | Ligands | 1 | 2019 | 664 | 0.030 |
Why?
| | Rabbits | 1 | 2018 | 794 | 0.030 |
Why?
| | Angiography | 1 | 2017 | 207 | 0.030 |
Why?
| | Random Allocation | 1 | 2017 | 353 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2020 | 528 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 431 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 691 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 324 | 0.030 |
Why?
| | Regeneration | 1 | 2018 | 197 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2018 | 319 | 0.030 |
Why?
| | Neovascularization, Pathologic | 1 | 2017 | 301 | 0.030 |
Why?
| | Incidence | 1 | 2022 | 2804 | 0.030 |
Why?
| | Actins | 1 | 2017 | 416 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 691 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2018 | 739 | 0.030 |
Why?
| | Amino Acids | 1 | 2018 | 497 | 0.030 |
Why?
| | Cognition | 1 | 2021 | 1153 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2069 | 0.030 |
Why?
| | Patient Care Team | 1 | 2018 | 631 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2020 | 2833 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 2486 | 0.020 |
Why?
| | MicroRNAs | 1 | 2019 | 692 | 0.020 |
Why?
| | Calcium | 1 | 2018 | 1199 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5742 | 0.020 |
Why?
| | Curriculum | 1 | 2018 | 992 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 7604 | 0.020 |
Why?
| | Child | 2 | 2022 | 21935 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2734 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5472 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2475 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3566 | 0.020 |
Why?
| | Macrophages | 1 | 2017 | 1547 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10388 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4295 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 5757 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 11074 | 0.010 |
Why?
| | Signal Transduction | 1 | 2019 | 5079 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 21513 | 0.010 |
Why?
|
|
Awad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|